Meditation Effects on Discomfort, Pain InTerference, and AnxieTy After urEteroscopy
Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Jan 15, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Context:
Pain is common after surgery to remove urinary stones, and current options for post-operative pain management are limited. Pre-operative anxiety is a well-known clinical entity that is associated with a higher risk of post-operative pain. Meditation is an ancient discipline that has been used for a wide range of presumed benefits including improving pain and anxiety. Meditation has been studied in a variety of clinical settings, but its effects have not been assessed among patients having ureteroscopy to remove kidney and/or ureteral stones.
Objectives:
To determine the effect o...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subjects age 12 years and older
- • 2. Diagnosis of unilateral or bilateral ureteral or renal stones
- • 3. Scheduled to undergo elective unilateral ureteroscopy for renal or ureteral stones in 2 or more weeks from initial clinic visit
- • 4. Parental/guardian permission (informed consent) and if appropriate, child assent.
- Exclusion Criteria:
- • 1. Participants \<12 years of age
- • 2. Subjects undergoing any other type of stone procedure (i.e. bilateral ureteroscopy, percutaneous nephrolithotomy, ESWL, staged ureteroscopy)
- • 3. Patients who are pre-stented at the initial clinic visit
- • 4. Non-English speaking participants
- • 5. Participants without functional e-mail address or phone
- • 6. Participants unable to use a computer/tablet independently
- • 7. Participants who will be undergoing ureteroscopy in less than 2 weeks from initial clinic visit
- • 8. Patients who are non-verbal or with cognitive delay that may impair ability to learn and adhere to intervention
- • 9. Patients with neurologic comorbidities that may alter sensation (eg. spinal cord injuries)
- • 10. Parents/guardians or subjects who, in the opinion of the investigator, may be non-compliant with study schedules or procedures
About Children's Hospital Of Philadelphia
The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Gregory E Tasian, MD
Principal Investigator
Children's Hospital of Philadelphia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported